DeepScribe provides an AI-powered platform that automatically transcribes clinician–patient conversations to help doctors keep more accurate notes. The product is used by more than 400 physicians. To expand its market and reach more doctors, the company turned to venture capital and raised $30 million. Index Ventures led the $30 million round, with Nina Achadjian serving as the Index contact. Co-founder and CEO Akilesh Bapu will discuss the company’s fundraising strategy and partnership with Index on a TechCrunch Live episode. The company plans to use the capital to reach even more physicians and expand its market reach. DeepScribe builds an ambient AI medical scribe that listens to doctor–patient interactions and automatically generates compliant clinical notes in the physician's EHR. Its AI model, developed at UC Berkeley’s AI Research Lab, combines classical rule‑based natural language processing with modern deep learning techniques to capture both sides of conversations and distill them into summaries. The system interfaces with major EHR platforms including AdvancedMD, AthenaHealth, Claimpower, Elation, DrChrono and PracticeFusion. The company was founded by Akilesh Bapu, Matthew Ko and Kairui Zeng and is based in San Francisco, CA. Financially, DeepScribe raised $5.2M in seed funding.

Total raised

$35M

Funding rounds

2

Latest round

Series A

Latest activity

Feb 2022